FDA Grants Dual Designations to Arbor's Gene...
CMN Clinical
Feb. 12, 2025
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Shape Therapeutics
Company Type: Therapeutic development
Main focus: Combining AI and RNA-editing technology to develop novel treatments for genetic diseases
Company stage: Pre-clinical
Diseases: Rett syndrome, Parkinson’s disease, and Alzheimer’s disease
Genome-editing tool: Proprietary RNA-editing platform RNAfix®
Funding stage: Series B
Location: Seattle, Washington, USA
Website: https://shapetx.com/
Pipeline:
Partners:
Shape Therapeutics (Shape TX) is a biotechnology company based in Seattle and Boston. The company aims to develop novel therapeutics to treat various diseases through RNA editing. Through merging the power of AI and RNA-editing technology, Shape TX aims to develop programmable RNA-editing treatments to correct the genetic causes of diseases.
